10 principais cel-sci.com concorrentes

vblrx.com

vbl therapeutics is a publicly traded (nasdaq: vblt), clinical stage biotechnology company committed to the discovery, development and commercialization of next-generation, targeted medicines for difficult-to-treat medical conditions.

neuroderm.com

NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.

leespharm.com

listed on the gem of the stock exchange of hong kong (“hkex”) limited since july 2002 and successfully transferred of listing to the main board of the hkex in may 2010, lee's pharmaceutical holdings limited (lee's pharm or “the group”) is an integrated research-driven and market oriented biopharmaceutical company publicly listed in hong kong with over 25 years’ experience in the pharmaceutical industry in china.

viedoc.com

Viedoc CRO partners are skilled, experienced, and certified to build cost-effective studies using our eClinical suite.

ichorms.com

Ichor's business model centers around providing access to its patented TriGrid® electroporation devices to enhance the performance of partners’ nucleic acid therapeutics and vaccines by improving delivery to target tissues. PARTNERS Ichor® has established several ongoing research and development collaborations and licensing agreements with leading research institutions such as Washington

pipelinereview.com

Get the latest biopharma news, clinical trial updates, and industry insights at PipelineReview.com. Discover innovative therapies and regulatory news.

surgery.wisc.edu

The Surgery Sett is dedicated to exploring the ideas, inventions and innovations of the worldwide surgical community and their intersections with the Department of Surgery at the University of Wisconsin. Host Jonathan Kohler, MD, interviews surgeons and other medical professionals who visit the UW Department of Surgery, along with surgeons and researchers from our own department.…